Skip to main content
Veterinary Medicines

CALMAGINE

Authorised
  • Metamizole

Product identification

Medicine name:
CALMAGINE
Active substance:
  • Metamizole
Target species:
  • Cattle
  • Pig
  • Cat
  • Equid
  • Dog
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Metamizole
    463.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        18
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        15
        day
    • Cat
    • Equid
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Dog
  • Intravenous use
    • Cattle
      • Meat and offal
        18
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        15
        day
    • Cat
    • Equid
      • Milk
        no withdrawal period
      • Meat and offal
        15
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02BB02
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/4053504 3/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."